Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2025-2032

The Food Allergy Diagnostics & Therapeutics Market is evolving as new allergen trends, technological innovation, and interdisciplinary care models reshape the future of diagnostics and therapeutics. Senior executives can leverage this report for actionable market intelligence and competitive advantage.

Market Snapshot: Food Allergy Diagnostics & Therapeutics Market

The global Food Allergy Diagnostics & Therapeutics Market recorded significant advancement, growing from USD 6.43 billion in 2024 to USD 7.14 billion in 2025. With a projected CAGR of 10.75%, the market is expected to reach USD 14.57 billion by 2032, underscoring strong momentum. Market growth is propelled by increasing allergy cases, the emergence of additional allergen categories, and continuous innovation across diagnostics and therapeutics. Intensifying competition and market fragmentation reflect both established industry presence and disruptive new entrants, as organizations pivot to deliver more precise and patient-responsive solutions.

Scope & Segmentation

This report offers a comprehensive breakdown of the Food Allergy Diagnostics & Therapeutics landscape, supporting data-driven decisions across product development, partnerships, and market entry strategies.

• Product Types: The segment includes At-Home Allergy Tests for consumer-level screening, Component Resolved Diagnostics for molecular-level identification, Skin Prick Tests and Specific IgE Tests for clinical precision, Antihistamines and Emergency Treatments for symptom management, Immunotherapy options such as Epicutaneous, Oral, and Subcutaneous delivery formats, and Monoclonal Antibodies targeting specific immune pathways.
• Allergen Types: Focuses on major food triggers including Egg, Fish, Milk, Peanut, Sesame, Shellfish, Soy, Tree Nut, and Wheat, capturing both common and emerging allergens under regulatory and clinical scrutiny.
• End Users: Encompasses Hospital Laboratories for comprehensive diagnostics, Point-Of-Care Settings for rapid intervention, Reference Laboratories for confirmatory analysis, and Research Institutes advancing the science behind diagnostics and therapeutics.
• Distribution Channels: Details access points such as Clinics & Diagnostic Centers, Hospitals, Online Platforms facilitating expanded reach, and Pharmacies supporting regular patient interaction.
• Regional Coverage: The report provides granular analysis across Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland), Middle East & Africa (United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan), enabling tailored market strategies.
• Key Companies Analyzed: The study presents detailed competitive profiles for Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, bioMérieux SA, Abbott Laboratories, Nestlé Health Science S.A., ALK-Abelló A/S, DBV Technologies S.A., Stallergenes Greer International S.A., and Aimmune Therapeutics LLC.

Key Takeaways for Decision-Makers

• Early identification of complex food allergies is now possible with advanced diagnostics, such as component resolved tests and scalable at-home solutions, which promote personalized and accessible care pathways.
• Artificial intelligence and biosensor technologies are improving diagnostic accuracy and enabling clinicians to predict allergic reactions with greater confidence, which streamlines operations and enhances patient safety.
• Monoclonal antibodies and tailored immunotherapy offer advanced management options, supporting chronic care and targeting a more diverse set of allergen exposures within varied patient populations.
• Collaborations among diagnostics providers, therapeutic innovators, and digital health organizations drive integrated care models from detection to ongoing disease management, increasing system efficiency.
• Emerging patient engagement tools—such as telemedicine platforms and digital health applications—enable continuous allergy monitoring and intervention, which is especially impactful in regions with high digital literacy.

Tariff Impact: United States Market

New U.S. tariffs initiated in 2025 are raising costs on imported diagnostic reagents and therapeutic components, impacting laboratory expenses and research investments. Organizations are responding by pursuing domestic manufacturing and prioritizing local supplier collaboration. Policymakers are being engaged by stakeholders to seek policy relief and ensure sustained patient access and uninterrupted continuity of care.

Methodology & Data Sources

This report is underpinned by a rigorous methodology involving comprehensive assessments of scientific studies, regulatory reviews, and industry publications, complemented by targeted primary interviews. Stakeholder perspectives from healthcare experts, senior corporate leaders, and clinical practitioners are synthesized through systematic peer review and triangulated for accuracy, ensuring robust and actionable recommendations.

Why This Report Matters: Strategic Insights for the Food Allergy Diagnostics & Therapeutics Market

• Provides senior leadership with a clear view of evolving technologies, regulatory changes, and shifting market structures, supporting proactive business adaptation.
• Guides resource allocation and partnership formation by clarifying segmentation and regional variances that shape commercial opportunity.
• Enhances operational agility through analysis of value chain vulnerabilities and opportunities for collaborative innovation, fortifying future competitiveness.

Conclusion

By delivering in-depth analysis and actionable findings, this report empowers executives to steer organizational strategy, address operational risks, and maintain resilient growth within the Food Allergy Diagnostics & Therapeutics sector.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.